Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain

References

• MercadanteSCancer painCurr Opin Support Palliat Care2013713914323572159
   PubMed Web of Science ®Google Scholar
• VentafriddaVTamburiniMCaraceniADe ConnoFNaldiFA validation study of the WHO method for cancer pain reliefCancer1987598508563802043
   PubMed Web of Science ®Google Scholar
• DaviesANDickmanAReidCStevensAMZeppetellaGScience Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and IrelandEur J Pain20091333133818707904
   PubMed Web of Science ®Google Scholar
• MercadanteSPortenoyRKOpioid poorly-responsive cancer pain. Part 1: clinical considerationsJ Pain Symptom Manage20012114415011226765
   PubMed Web of Science ®Google Scholar
• PortenoyRKHagenNABreakthrough pain: definition, prevalence and characteristicsPain1990412732811697056
   PubMed Web of Science ®Google Scholar
• PortenoyRKPayneDJacobsenPBreakthrough pain: characteristics and impact in patients with cancer painPain1999811293410353500
   PubMed Web of Science ®Google Scholar
• MercadanteSRadbruchLCaraceniASteering Committee of the European Association for Palliative Care (EAPC) Research NetworkEpisodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative CareCancer20029483283911857319
   PubMed Web of Science ®Google Scholar
• MercadanteSPharmacotherapy for breakthrough cancer painDrugs20127218119022233484
   PubMed Web of Science ®Google Scholar
• CaraceniAMartiniCZeccaEBreakthrough pain characteristics and syndromes in patients with cancer pain: an international surveyPalliat Med20041817718315198130
   PubMed Web of Science ®Google Scholar
• PortenoyRKBrunsDShoemakerBShoemakerSABreakthrough pain in community-dwelling patients with cancer pain and noncancer pain. Part 1: prevalence and characteristicsJ Opioid Manag201069710820481174
   PubMedGoogle Scholar
• MercadanteSCostanzoBVFuscoFBreakthrough pain in advanced cancer patients followed at home: a longitudinal studyJ Pain Symptom Manage20093855456019692200
   PubMed Web of Science ®Google Scholar
• MercadanteSZagonelVBredaEBreakthrough pain in oncology: a longitudinal studyJ Pain Symptom Manage20104018319020447801
   PubMed Web of Science ®Google Scholar
• PortenoyRKBennettDSRauckRPrevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer painJ Pain2006758359116885015
   PubMed Web of Science ®Google Scholar
• DickmanABasics of managing breakthrough cancer painPharm J2009283213e216
   Google Scholar
• FortnerBVOkonTAPortenoyRKA survey of pain-related hospitalizations, emergency department visits, and physician office visits by cancer patients with and without breakthrough painJ Pain20023384414622852
   PubMed Web of Science ®Google Scholar
• FortnerBVDemarcoGIrvingGDescription and predictors of direct and indirect costs of pain reported by cancer patientsJ Pain Symptom Manage20032591812565184
   PubMed Web of Science ®Google Scholar
• SmithHA comprehensive review of rapid-onset opioids for breakthrough painCNS Drugs20122650953522668247
   PubMed Web of Science ®Google Scholar
• ZeppetellaGOpioids for the management of breakthrough cancer pain in adults: a systematic review undertaken as part of an EPCRC opioid guidelines projectPalliat Med20102551652421708858
   PubMed Web of Science ®Google Scholar
• ZeppetellaGDynamics of breakthrough pain vs pharmacokinetics of oral morphine: implications for managementEur J Cancer Care200918331337
   PubMed Web of Science ®Google Scholar
• McWilliamsKFallonMFast-acting fentanyl preparations and pain managementQJM201310688789023613597
   PubMed Web of Science ®Google Scholar
• JandhyalaRFullartonJRBennettMIEfficacy of rapid-onset oral fentanyl formulations vs oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trialsJ Pain Symptom Manage212013 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Di PalmaMPoulainPPichardEWhat’s new in the treatment of cancer pain?Bull Cancer2004919598 French14975810
   PubMed Web of Science ®Google Scholar
• MercadanteMA comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trialCurr Med Res Opin2009252805281519792837
   PubMed Web of Science ®Google Scholar
• IMS HealthNational sales data July 2011–January 2012 for rapid onset opioids, oral morphine and oxycodone for Spain. Data on file
   Google Scholar
• International Association for Cancer ResearchGLOBCAN cancer incidence, mortality and prevalence worldwide in 2008 Available from: http://globocan.iarc.fr/summary_table_site_prev.asp?selection=280&title=All+cancers+excl.+nonAccessed May 8, 2013
   Google Scholar
• Instituto Nacional de Estadístico. [National institure for statistics. Projections for the population on the short term.]Proyecciones de población a corto plazo2011–2021 Available from: http://www.ine.es/jaxi/menu.do?type=pcaxis&path=%2Ft20%2Fp269%2F2011-2021&file=pcaxis&L=Accessed October 12, 2012
   Google Scholar
• Gómez-BatisteXMadridFMorenoFBreakthrough cancer pain: prevalence and characteristics in patients in Catalonia, SpainJ Pain Symptom Manage200224455212183094
   PubMed Web of Science ®Google Scholar
• FallonMRealeCDaviesAFentanyl nasal spray study. Efficacy and safety of fentanyl pectin nasal spray compared with immediate-release morphine sulfate tablets in the treatment of breakthrough cancer pain: a multicenter, randomized, controlled, double-blind, double-dummy multiple-crossover studyJ Support Oncol2011922423122055892
   PubMedGoogle Scholar
• Agencia de Medicamentos y Productos Sanitarios EspañolaFicha técnica de Actiq® Available from: http://www.aemps.gob.es/cima/fichasTecnicas.do?metodo=buscarAccessed June 25, 2013
   Google Scholar
• Agencia de Medicamentos y Productos Sanitarios EspañolaFicha técnica de Abstral® Available from: http://www.aemps.gob.es/cima/fichasTecnicas.do?metodo=buscarAccessed June 25, 2013
   Google Scholar
• Agencia de Medicamentos y Productos Sanitarios EspañolaFicha técnica de PecFent® Available from: http://www.aemps.gob.es/cima/fichasTecnicas.do?metodo=buscarAccessed June 25, 2013
   Google Scholar
• Agencia de Medicamentos y Productos Sanitarios EspañolaFicha técnica de Instanyl® Available from: http://www.aemps.gob.es/cima/fichasTecnicas.do?metodo=buscarAccessed June 25, 2013
   Google Scholar
• Agencia de Medicamentos y Productos Sanitarios EspañolaFicha técnica de Effentora® Available from: http://www.aemps.gob.es/cima/fichasTecnicas.do?metodo=buscarAccessed June 25, 2013
   Google Scholar
• Consejo General de Colegios Oficiales de FarmacéuticosBOT plus web2012 Available from: https://botplusweb.portalfarma.com/Accessed May 8, 2013
   Google Scholar
• Real Decreto-Ley 8/2010, May 20th where extraordinary measures were adopted for public deficit reduction
   Google Scholar
• DavisMPRecent development in therapeutics for breakthrough painExpert Rev Neurother20101075777320420495
   PubMed Web of Science ®Google Scholar
• DaviesANVriensJKennettAMcTaggartMAn observational study of oncology patients’ utilization of breakthrough pain medicationJ Pain Symptom Manage20083540641118222631
   PubMed Web of Science ®Google Scholar
• FerrellBRJuarezGBornemanTUse of routine and breakthrough analgesia in home careOncol Nurs Forum1999261655166110573682
   PubMedGoogle Scholar
• Ramos GraciaMCatala HortelanoLSala LangaMJGómez SánchezDConejero MorantMASaneugenio GregoriJAccidental poisoning by intranasal fentanylAn Pediatr (Barc)5152013 [Epub ahead of print.] Spanish
   Web of Science ®Google Scholar
• VissersDStamWNolteTLenreMJansenJEfficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancerCurr Med Res Opin2010261037104520199140
   PubMed Web of Science ®Google Scholar
• VissersDCLenreMTolleyKJakobssonJSenderskyVJansenJPAn economic evaluation of short-acting opioids for treatment of breakthrough pain in patients with cancerValue Health20111427428121402296
   PubMed Web of Science ®Google Scholar
• Diari Oficial de la Generalitat de Catalunya (DOGC) Núm. 5325 – 24.2.2009 Available at: http://www20.gencat.cat/portal/site/portaldogcAccessed June, 2013
   Google Scholar
• Diari Oficial de la Generalitat de Catalunya (DOGC) Núm. 5907 – 27.6.2011 Available at: http://www20.gencat.cat/portal/site/portaldogcAccessed June, 2013
   Google Scholar
• Diario Oficial de Galicia. (DOG) Núm. 213 Martes, 8 de noviembre de 2011 Pág. 32557 Available at: http://www.xunta.es/diario-oficial-galicia/8Accessed June, 2013
   Google Scholar
• Boletin Oficial de Cantabria. (DOC) Núm. 85 Jueves, 5 de mayo de 2011. Pág. 15393 Available at: http://boc.cantabria.es/boces/Accessed June, 2013
   Google Scholar